No, Retatrutide and Ozempic (semaglutide) are not the same, but they are both medications used for weight loss and diabetes management, acting through different mechanisms.
Key Differences Between Retatrutide and Ozempic
| Feature | Retatrutide | Ozempic (Semaglutide) |
|---|---|---|
| Drug Class | Triagonist (GLP-1, GIP, Glucagon) | GLP-1 Receptor Agonist |
| Mechanism | Activates GLP-1, GIP, and Glucagon receptors, enhancing insulin release, appetite suppression, and fat metabolism | Works only on GLP-1 receptors, increasing insulin release and reducing appetite |
| Intended Use | Type 2 diabetes, weight loss, metabolic disorders | Type 2 diabetes, weight loss (as Wegovy) |
| Weight Loss Effectiveness | More effective due to multi-receptor action | Effective but less than Retatrutide |
| Manufacturer | Eli Lilly | Novo Nordisk |
Which is Better for Weight Loss?
Retatrutide has shown greater weight loss potential than Ozempic in clinical trials due to its additional GIP and glucagon activity.
Ozempic is widely used and well-studied but primarily works through GLP-1 alone.
